Multimedia
Covid-19 helped India develop ecosystem for drug discovery, administration: Dr Swati Piramal
Dr Swati Piramal is a senior public health expert and a leading face of India's drug discovery processes. She explains how Covid-19 helped the Indian drug discovery ecosystem evolve to world-class capabilities.
Companies, the Government and regulatory authorities joined forces and acted quickly to find and bring vaccine technology, manufacture doses on large scale, and administer to over 100 crore Indians in a quick time, which is a great feat. This will help India scale new frontiers in drug discovery.
Also Read
-
Tata Technologies FY24 profit surges 9% at ₹679 cr; revenue grows 16%
-
WhatsApp India bans 2.2 crore accounts in Jan-March
-
Titan Q4 profit rises 5% to ₹771 crore
-
Adani Green Q4 profit drops 39% to ₹310 cr
-
Godrej Properties Q4 profit up 14%; revenue down 13% to ₹1,426 cr